Review
doi: 10.1056/NEJMra1503523.
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
- PMID: 26840135
- DOI: 10.1056/NEJMra1503523
Item in Clipboard
Review
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
N Engl J Med.
.
No abstract available
Comment in
-
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.N Engl J Med. 2016 Jun 16;374(24):2404. doi: 10.1056/NEJMc1602861. N Engl J Med. 2016. PMID: 27305204 No abstract available.
-
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.N Engl J Med. 2016 Jun 16;374(24):2403. doi: 10.1056/NEJMc1602861. N Engl J Med. 2016. PMID: 27305205 No abstract available.
-
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.N Engl J Med. 2016 Jun 16;374(24):2403-4. doi: 10.1056/NEJMc1602861. N Engl J Med. 2016. PMID: 27305206 No abstract available.
Similar articles
-
Prevention and management of hereditary breast cancer.J Clin Oncol. 2005 Mar 10;23(8):1656-63. doi: 10.1200/JCO.2005.10.035. J Clin Oncol. 2005. PMID: 15755973 Review. No abstract available.
-
Choices--and uncertainties--for women with BRCA mutations.Science. 2003 Oct 24;302(5645):592. doi: 10.1126/science.302.5645.592. Science. 2003. PMID: 14576419 No abstract available.
-
Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.Clin Genet. 2014 Jan;85(1):21-30. doi: 10.1111/cge.12233. Epub 2013 Aug 26. Clin Genet. 2014. PMID: 23859469
-
Breast cancer prevention in high-risk women: searching for new options.J Natl Cancer Inst. 2011 May 4;103(9):710-1. doi: 10.1093/jnci/djr159. Epub 2011 Apr 22. J Natl Cancer Inst. 2011. PMID: 21515834 No abstract available.
-
Prophylactic surgery in hereditary breast/ovarian cancer syndrome.Oncology (Williston Park). 2003 Jul;17(7):932-41; discussion 946-8, 950-2. Oncology (Williston Park). 2003. PMID: 12886864 Review.
Cited by
-
Prophylactic Bilateral Salpingo-oophorectomy in BRCA2 Mutation with Incidental Finding of Serous Tubal Intraepithelial Carcinoma (STIC) and Subsequent Diagnosis of Primary Peritoneal Carcinoma (PPC): A Case Report and Review of Current Literature.Cureus. 2020 Jul 20;12(7):e9301. doi: 10.7759/cureus.9301. Cureus. 2020. PMID: 32832298 Free PMC article.
-
Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report.J Ovarian Res. 2022 Dec 3;15(1):127. doi: 10.1186/s13048-022-01069-y. J Ovarian Res. 2022. PMID: 36463302 Free PMC article.
-
The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication.Curr Oncol. 2023 Feb 17;30(2):2429-2440. doi: 10.3390/curroncol30020185. Curr Oncol. 2023. PMID: 36826146 Free PMC article. Review.
-
Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma.J Clin Med Res. 2023 Feb;15(2):68-75. doi: 10.14740/jocmr4853. Epub 2023 Feb 28. J Clin Med Res. 2023. PMID: 36895622 Free PMC article. Review.
-
Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?Breast. 2020 Feb;49:81-86. doi: 10.1016/j.breast.2019.10.012. Epub 2019 Nov 6. Breast. 2020. PMID: 31760168 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
